| Literature DB >> 27761492 |
Chih-Yao Chung1, Wen-Chin Yang2, Chih-Lung Liang3, Hsien-Yueh Liu1, Shih-Kai Lai1, Cicero Lee-Tian Chang1.
Abstract
Cytopiloyne (CP), a novel polyacetylene compound extracted from B. pilosa, shows a multi-bioactivity, including immunomodulatory and antidiabetes. Here, we investigated the anti-Listeria effect of cytopiloyne in mice by assessing mortality, clearance of L. monocytogenes, and pathology examination. The data presented herein are supplemental to our research article entitled "Cytopiloyne, a polyacetylenic glucoside from Bidens pilosa, acts as a novel anticandidial agent via regulation of macrophages" [1].Entities:
Year: 2016 PMID: 27761492 PMCID: PMC5063800 DOI: 10.1016/j.dib.2016.03.044
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Cytopiloyne (CP) dose-dependently protected mice against L. monocytogenes infection (n=10 in each groups).
Fig. 2Cytopiloyne (CP) lowered the CFU counts and severity of lesions in Listeria-infection mice. (A) Gross pathology observation of livers of PBS-(Ctr) and CP-treated mice at 3 days post infection. Diffuse microabscesses were observed in liver of PBS-treated (Ctr) mice, while only focal microabscesses indicated by arrows were noted in CP-treated (CP) mice. (B) CP lowered the CFU counts in liver and spleen (n=3–6 in each groups). (C–H) Histopathology observation (H and E) of livers of PBS-(C and D, at 3 days post infection) and CP-treated (E and F, at 3 days post infection; G and H, at 13 days post infection) mice. C, E, and G: 100×; D, F, and H: 400×. (I–N) Histopathology observation (Gram staining) of livers of PBS-(I and J, at 3 days post infection) and CP-treated (K and L, at 3 days post infection; M and N, at 13 days post infection) mice. I, K, and M: 400×; J, L, and N: 1000×.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |